Back
Oracle Vs. Lyra Therapeutics Industry Stock Comparison
Buy
67
ORCL
Oracle
Last Price:
$237.23
Seasonality Move:
4.06%
Sell
32
LYRA
Lyra Therapeutics
Last Price:
$9.16
Seasonality Move:
-2.29%
Sell
32
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $9.00. The Score for LYRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $9.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight selling pressure.
ORCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.77 | Buy |
Relative Strength Index (14 RSI): | 80.33 | Buy |
Chaikin Money Flow: | 14802478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (174.23 - 219.35) | Buy |
Bollinger Bands (100): | (137.41 - 189.01) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 44.26 | Sell |
Chaikin Money Flow: | -16263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.53 - 19.57) | Sell |
Bollinger Bands (100): | (4.06 - 13.18) | Buy |
ORCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 219.24 | Buy |
20-day SMA: | 204.38 | Buy |
50-day SMA: | 174.21 | Buy |
200-day SMA: | 168.32 | Buy |
8-day EMA: | 220.99 | Buy |
20-day EMA: | 205.84 | Buy |
50-day EMA: | 183.88 | Buy |
200-day EMA: | 163.15 | Buy |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.48 | Sell |
20-day SMA: | 12.91 | Sell |
50-day SMA: | 9.32 | Sell |
200-day SMA: | 9.78 | Sell |
8-day EMA: | 10.03 | Sell |
20-day EMA: | 11.05 | Sell |
50-day EMA: | 10.19 | Sell |
200-day EMA: | 21.81 | Sell |
Oracle Earnings Growth & ORCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.28 per share, an increase this year of $0.41 per share, and an increase next year of $1.23 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Oracle Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |